Although its track record at the state level may not be perfect, medical marijuana has scored far more victories than defeats in recent years.

Medical marijuana spreads its wings

Following its first approval 20 years ago in California for compassionate use cases, medical marijuana has now become legal in 24 states, as well as Washington, D.C. The latest state to legalize the use of medical marijuana was just as much of an eye-opener as the first. Pennsylvania legalized the use of liquid, pill, or oil formulations of marijuana for medicinal use in mid-April, though it did so entirely at the legislative level (i.e., without residents voting). Pennsylvania could be the first of many states taking matters into their own hands from a legalization perspective.

Who was the first U.S. president to smoke marijuana in office? Some argue that President George Washington grew marijuana on Mount Vernon for his own personal, medical use. But the honor of America's first commander-in-chief to use cannabis medicinally may actually belong to John F. Kennedy - who was born 99 years ago today.

When it comes to history, there are a lot of things that get left out of textbooks for various reasons – and even through multiple World History and American History classes, I can’t recall a single bit of information about cannabis prior to the Reefer Madness Era. Perhaps there was a quick mention of things made of hemp, but no real background on the plant, how its uses were discovered or how it made it made its way pretty much all over the world.

The U.S. Drug Enforcement Agency is about to make a decision that could have wide-ranging implications on the state-sanctioned marijuana industry: to reschedule or not to reschedule marijuana's position as an illegal substance.

It's become a familiar lament in the age of legal marijuana: Weed from places like Colorado and Washington is making its way all over the country, creating headaches for law enforcement.

He has virtually no money, no strategy to compete in battleground states and no plan to stop talking about his drug use.

Yet with the Republican Party facing the prospect of a Donald Trump presidency, Libertarian presidential hopeful Gary Johnson could be a factor in 2016. The former two-term New Mexico governor, a Republican businessman perhaps best known for his years-long push to legalize marijuana, has a sobering message for a “never-Trump” movement desperately seeking a viable alternative.

“I will be the only third-party candidate on the ballot in all 50 states,” Johnson says. “I’m it.”

When a Vietnamese attendee at a town hall asked Pres. Obama about his weed-smoking past, the U.S. president replied that he “didn’t know” if reports of his marijuana use were true. And, after expounding on his personal turn-around, warned, “Don’t believe everything you read on the Internet.

Speaking to a group of young Vietnamese leaders in Ho Chi Minh city, Obama was hit with the accusation and asked to explain how and why he got his life together and went on to achieve greatness:

The lawmaker behind the plan to have a pharmacist in every dispensary says it's the most responsible way to oversee marijuana as medicine.

A legislative proposal to regulate medical marijuana through Ohio’s pharmacy board was scrapped Tuesday over concerns the rare setup nationally would create an undue burden on the state.

Republican Sen. David Burke, a Marysville pharmacist behind the idea, called the arrangement the most responsible way to oversee marijuana as medicine. He said changes introduced in the Senate Government Oversight Committee on Tuesday were needed to strike a workable compromise.

Jason Pinsky is a passionate advocate for cannabis legislation in New York. His own personal struggle to overcome a dependency to OxyContin after spinal surgery 15-years ago thrusted him into the cannabis advocacy and legislation sphere.  He was instrumental in the 2014 legislation that legalized cannabis for a select few within the state, and now he wants to improve the program so that everyone who needs medical cannabis can get it.

Insys Therapeutics, Inc. (NASDAQ: INSY) (“Insys” or “the Company”) today announced that it has successfully completed its Phase 1/Phase 2 safety and pharmacokinetic (PK) study in pediatric subjects with treatment-resistant epilepsy.

In this trial, 61 subjects with refractory epilepsy, between the ages of 1 year to 17 years, received treatment with Insys’ pharmaceutical cannabidiol (CBD) oral solution across multiple investigative sites in the United States.  The clinical trial evaluated multiple ascending doses of Insys’ CBD with three cohorts of subjects receiving total daily doses of 10 mg/kg, 20 mg/kg or 40 mg/kg.  Over 80% of these subjects continue to receive CBD in an ongoing long-term safety study.